Triple HIV/HBV/HCV screening alert in primary care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses a within-subjects design where each provider encounters both a control period (no alert) and an intervention period (an EMR alert linked to a triple-testing order panel). The alert appears when a BBV screening test is being ordered and shows the default triple-test order set for adult patients. Providers can see which tests are selected before finalizing orders, and the study collects data on how often the alert changes ordering behavior. The trial is conducted at UT Southwestern with collaboration from Gilead Sciences and focuses on outpatient adult primary care providers.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Outpatient primary care adult providers at participating institutions
* Providers who provide consent to participate in this study.
* Providers must intend to continue their current practice for at least 12 months.
* Providers with at least 12 months experience in their current practice.

Exclusion Criteria:

* Providers who do not consent to participate
* Sub-specialty providers
* Pediatric providers
* Providers who anticipate leaving their current practice within the next 12 months (i.e. providers who plan to retire, move, etc.).
* Providers with less than 12 months experience in their current practice (i.e. new providers or trainees who joined the practice within the last year)
* Note: family medicine and med/peds providers can participate, but only for their adult patients. The intervention alert+order panel and any data collection will be restricted to adult patients ≥ 18 years old.

Where it's running

• University of Texas Southwestern Medical Center
  Dallas, Texas, United States Recruiting

Study contacts

• Principal investigator: Mamta K Jain, MD, MPH — University of Texas Southwestern Medical Center
• Study coordinator: Nicole E Naiman, MD/PhD
• Email: nicole.naiman@utsouthwestern.edu
• Phone: 214-645-9317

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MagIA H3S multiplex rapid blood test for HIV, hepatitis B and C, and syphilis

  This project will test a single blood-based point-of-care test that checks for HIV, hepatitis B and C, and syphilis using serum or plasma samples from people at sites in Ivory Coast and Kenya.

  Recruiting at 2 sites MagIA Diagnostics · Abidjan and 1 other locations · NCT07170748

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.